Aragen Life Sciences standalone net profit declines 20.10% in the December 2024 quarter
Sales rise 3.21% to Rs 391.66 crore
Net profit of Aragen Life Sciences declined 20.10% to Rs 45.91 crore in the quarter ended December 2024 as against Rs 57.46 crore during the previous quarter ended December 2023. Sales rose 3.21% to Rs 391.66 crore in the quarter ended December 2024 as against Rs 379.48 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales391.66379.48 3 OPM %26.2231.30 -PBDT101.67117.14 -13 PBT65.1176.71 -15 NP45.9157.46 -20Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content